The results showed that MAGI1 mutations or copy number alterations (CNA) are rare as they are observed in less than 3% of all breast cancers, and 2% within ER+/HER2− BC (Figure 8a), indicating that DNA alterations are not the major cause of MAGI1 downregulation. This evidence concerns the gene ERBB2 and breast cancer.